Speaker illustration

Doctor Lorenzo Martin Lobo

Campo de Mayo Military Hospital, Buenos Aires (Argentina)

Dr. Lorenzo Martin Lobo is: Cardiologist Head of Department Cardiovascular disease and Cardiometabolism (Campo de Mayo Military Hospital). Chief of Cardiology Campo de Mayo Military Hospital Full Member of the Argentine Society of Cardiology Fellow of the American College of Cardiology Fellow of the European Society of Cardiology Former Director of the Atherosclerosis and Thrombosis council of the SAC Advisory Member of the Atherosclerosis and Thrombosis council of the SAC Former Director of the Epidemiology and Cardiovascular Prevention council of the SAC Advisory Member of the Epidemiology and Cardiovascular Prevention council of the SAC Lipid expert of the Argentine Lipid Society. Member of the Argentine Lipid Society. ACLS Instructor of the American Heart Association

Statins and influenza mortality: systematic review and meta-analysis.

Event: ESC Congress 2022

Topic: Epidemiology

Session: Risk factors and prevention - Epidemiology 1

Thumbnail

Effectiveness of roux-en-Y gastric bypass vs sleeve gastrectomy on lipid levels in type 2 diabetes: a meta-analysis

Event: ESC Congress 2022

Topic: Lipids

Session: Lipids 1

Thumbnail

Role of statins in patients with MINOCA. A systematic review and meta-analysis.

Event: ESC Congress 2021 - The Digital Experience

Topic: Secondary Prevention

Session: Risk Factors and Prevention ePosters

Thumbnail

Non-statin lipid-lowering therapy in coronary atherosclerosis regression: A meta-analysis and meta-regression.

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Secondary Prevention

Session: Non-statin Treatment of Dyslipidemia

Thumbnail

Role of colchicine in stroke prevention: An updated meta-analysis.

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Epidemiology

Session: Risk Factors and Prevention ePosters

Thumbnail

Aspirin in primary prevention. Risks and benefits. Up date 2019. A meta-analysis

Event: ESC CONGRESS 2019

Topic: Cardiovascular Risk Assessment

Session: Atrial fibrillation, anti-platelet therapy, anticoagulation and bleeding

Thumbnail

Therapy with cholesteryl ester transfer protein (CETP) inhibitors and diabetes risk . A Meta-analysis.

Event: ESC Congress 2018

Topic: Drug therapy

Session: HDL cholesterol - A moving target

Thumbnail

ESC 365 is supported by

logo Novo Nordisk